Skip to main content
TipRanks
Go Ultimate75% OFF

Graham Griffiths Insider Profile

4 Followers

Graham Griffiths, former CBO at Barinthus Biotherapeutics, holds 104.21K shares in Barinthus Biotherapeutics (Ticker: BRNS). Most recently, Graham Griffiths Sold 10,000 shares of Barinthus Biotherapeutics on Aug 26, 2022 for an estimated value of $73.80K.

Graham Griffiths's Trading History

BRNS
Barinthus Biotherapeutics
Aug 26, 2022―Informative Sell73.80K$77.11K
BRNS
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 26, 2022Informative Sell$73.80K10,000$7.38+61.10%
Aug 19, 2022Informative Sell$2.38K500$4.76+56.40%
Aug 17, 2022Informative Sell$17.27K3,620$4.77+59.10%
Aug 15, 2022Informative Sell$22.50K5,000$4.50+54.90%
Jul 15, 2022Informative Sell$42.248$5.28+50.20%

You May Also Like

Graham Griffiths insider profile FAQ

What is the percentage of profitable transactions made by Graham Griffiths?
The percentage of profitable transactions made by Graham Griffiths is 83%.
What is the average return per transaction made by Graham Griffiths?
The average return per transaction made by Graham Griffiths is 36.50%.
What stocks does Graham Griffiths hold?
Graham Griffiths holds: BRNS stocks.
What was Graham Griffiths’s latest transaction?
Graham Griffiths’s latest transaction was an Informative Sell of $73.80K.
What was Graham Griffiths's most profitable transaction?
Graham Griffiths’s most profitable transaction was an Informative Sell of BRNS stock on August 26, 2022. The return on the trade was 61.10%.
What is Graham Griffiths's role in Barinthus Biotherapeutics?
Graham Griffiths's role in Barinthus Biotherapeutics is CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.